Intech Biopharm Corporation (TPEX:6461)
Taiwan · Delayed Price · Currency is TWD 24.40
+0.10 (0.41%)
Sep 30, 2026, 12:36 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 2.68 billion as of September 29, 2026. Its market cap has decreased by -8.58% in one year.
Market Cap
2.68B
Enterprise Value
3.86B
Revenue
48.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.40
ChartMarket Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 2.68B, a decrease of -33.05%. That is a compound annual growth rate of -3.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 2.68B | -7.55% |
| Dec 31, 2025 | 2.90B | -20.37% |
| Dec 31, 2024 | 3.64B | -11.36% |
| Dec 29, 2023 | 4.11B | 5.65% |
| Dec 30, 2022 | 3.89B | 67.22% |
| Dec 30, 2021 | 2.33B | 11.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sunhawk Vision Biotech | 3.16B |
| Sagittarius Life Science | 3.16B |
| Shine-On BioMedical | 3.15B |
| Senhwa Biosciences | 3.05B |
| Energenesis Biomedical CO.,LTD. | 2.85B |
| Chunghwa Chemical Synthesis & Biotech | 2.59B |
| GlycoNex Incorporation | 2.47B |
| HeXun Biosciences | 2.29B |